Trice Medical's joint injury device earns FDA approval

The Food and Drug Administration recently approved the Mi-eye 2, a second-generation device used to diagnose and treat joint injuries, reports Philadelphia Business Journal.

Mi-eye 2, developed by Trice Medical, contains a disposable needle with a fully integrated camera, according to the report. Physicians use the device to illuminate and better visualize what's happening inside a patient's body during diagnostic and operative arthroscopic or endoscopic procedures.

The FDA approved the original Mi-eye device in 2014. Mi-eye 2 offers several improvements, including better resolution, field of view, depth of field and overall visualization, according to Jeffrey O'Donnel, president and CEO of King of Prussia, Penn.-based Trice Medical.

More articles on supply chain:

Novartis restructures research unit, sheds 175 jobs: 4 things to know
Insmed buys AstraZeneca's respiratory drug for $150M: 5 things to know
FedEx to open new Ohio distribution center in 2017

 

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars